(Q43551135)

English

Risk-adjusted monitoring of veno-occlusive disease following Bayesian individualization of busulfan dosage for bone marrow transplantation in paediatrics

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Risk-adjusted monitoring of veno-occlusive disease following Bayesian individualization of busulfan dosage for bone marrow transplantation in paediatrics (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

author name string

Kitio Brice

1

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Bertholle Valerie

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Galambrun Claire

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Mialou Valerie

4

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Bertrand Yves

5

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Aulagner Gilles

6

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Bleyzac Nathalie

7

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

publication date

1 February 2008

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Pharmacoepidemiology and Drug Safety

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

135-143

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Improved clinical outcome of paediatric bone marrow recipients using a test dose and Bayesian pharmacokinetic individualization of busulfan dosage regimens

1 reference

https://api.crossref.org/works/10.1002%2FPDS.1504

21 January 2018

Veno-occlusive disease of the liver after hemopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FPDS.1504

21 January 2018

Risk-adjusted monitoring of binary surgical outcomes

1 reference

https://api.crossref.org/works/10.1002%2FPDS.1504

21 January 2018

Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-

1 reference

https://api.crossref.org/works/10.1002%2FPDS.1504

21 January 2018

Robust optimal design for the estimation of hyperparameters in population pharmacokinetics.

1 reference

https://api.crossref.org/works/10.1002%2FPDS.1504

21 January 2018

Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients

1 reference

https://api.crossref.org/works/10.1002%2FPDS.1504

21 January 2018

Incidence, survival and risk factors for the development of veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients.

1 reference

https://api.crossref.org/works/10.1002%2FPDS.1504

21 January 2018

Development of a pharmacokinetic and Bayesian optimal sampling model for individualization of oral busulfan in hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FPDS.1504

21 January 2018

Population pharmacokinetic analysis resulting in a tool for dose individualization of busulphan in bone marrow transplantation recipients

1 reference

https://api.crossref.org/works/10.1002%2FPDS.1504

21 January 2018

Individualizing high-dose oral busulfan: prospective dose adjustment in a pediatric population undergoing allogeneic stem cell transplantation for advanced hematologic malignancies

1 reference

https://api.crossref.org/works/10.1002%2FPDS.1504

21 January 2018

Therapeutic monitoring of busulfan in pediatric bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1002%2FPDS.1504

21 January 2018

The hidden effect of time.

1 reference

https://api.crossref.org/works/10.1002%2FPDS.1504

21 January 2018

Use of risk-adjusted CUSUM and RSPRT charts for monitoring in medical contexts

1 reference

https://api.crossref.org/works/10.1002%2FPDS.1504

21 January 2018

Transplant center quality assessment using a continuously updatable, risk-adjusted technique (CUSUM).

1 reference

https://api.crossref.org/works/10.1002%2FPDS.1504

21 January 2018

Hepatic venoocclusive disease in blood and bone marrow transplantation in children and young adults: incidence, risk factors, and outcome in a cohort of 241 patients

1 reference

https://api.crossref.org/works/10.1002%2FPDS.1504

21 January 2018

Identifiers

10.1002/PDS.1504

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43551135&oldid=2100704038"